{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T21:33:34Z","timestamp":1781904814258,"version":"3.54.5"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ando.2025.101693","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T16:23:35Z","timestamp":1736871815000},"page":"101693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Chapter 4: Differential diagnosis of primary hyperparathyroidism"],"prefix":"10.1016","volume":"86","author":[{"given":"Peter","family":"Kamenick\u00fd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Houillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Vantyghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2025.101693_bib0380","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0002-9343(78)90814-8","article-title":"Divalent cation metabolism. Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism","volume":"65","author":"Marx","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2025.101693_bib0385","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1210\/jc.2015-3442","article-title":"Familial hypocalciuric hypercalcemia types 1 and 3 and primary hyperparathyroidism: similarities and differences","volume":"101","author":"Vargas-Poussou","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ando.2025.101693_bib0390","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s42000-023-00508-9","article-title":"Genetics of hereditary forms of primary hyperparathyroidism","volume":"23","author":"English","year":"2024","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.ando.2025.101693_bib0395","doi-asserted-by":"crossref","first-page":"e156742","DOI":"10.1172\/jci.insight.156742","article-title":"Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused by biased allosteric CaSR autoantibodies","volume":"7","author":"Makita","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.ando.2025.101693_bib0400","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ando.2023.03.004","article-title":"Iatrogenic endocrine complications of lithium therapy","volume":"84","author":"Vantyghem","year":"2023","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2025.101693_bib0405","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ecl.2021.08.001","article-title":"Drug-related hypercalcemia","volume":"50","author":"Lecoq","year":"2021","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ando.2025.101693_bib0410","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1172\/JCI6629","article-title":"Ablation of the PTHrP gene or the PTH\/PTHrP receptor gene leads to distinct abnormalities in bone development","volume":"104","author":"Lanske","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ando.2025.101693_bib0415","doi-asserted-by":"crossref","first-page":"249","DOI":"10.11005\/jbm.2017.24.4.249","article-title":"Clinical characteristics, causes and survival in 115 cancer patients with parathyroid hormone related protein-mediated hypercalcemia","volume":"24","author":"Jin","year":"2017","journal-title":"J Bone Metab"},{"key":"10.1016\/j.ando.2025.101693_bib0420","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1210\/jc.2014-4250","article-title":"PTHrP-mediated hypercalcemia: causes and survival in 138 patients","volume":"100","author":"Donovan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101693_bib0425","doi-asserted-by":"crossref","first-page":"e256126","DOI":"10.1136\/bcr-2023-256126","article-title":"Hypercalcaemia of malignancy: a case of vitamin-D-mediated hypercalcaemia in lymphoma","volume":"17","author":"Mehta","year":"2024","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ando.2025.101693_bib0430","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ando.2023.05.009","article-title":"Case report: non-PTH-dependent hypercalcemia in pregnancy: consider CYP24A1 mutations","volume":"84","author":"Lemaitre","year":"2023","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2025.101693_bib0435","doi-asserted-by":"crossref","first-page":"64","DOI":"10.6065\/apem.2019.24.1.64","article-title":"Infantile hypercalcemia with novel compound heterozygous mutation in SLC34A1 encoding renal sodium-phosphate cotransporter 2a: a case report","volume":"24","author":"Kang","year":"2019","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101693_bib0440","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ando.2016.03.002","article-title":"Hyperparathyroidism complicating CYP 24A1 mutations","volume":"77","author":"Loyer","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2025.101693_bib0445","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziae012","article-title":"Loss of 24-hydroxylated catabolism increases calcitriol and fibroblast growth factor 23 and alters calcium and phosphate metabolism in fetal mice","volume":"8","author":"Bennin","year":"2024","journal-title":"JBMR Plus"},{"key":"10.1016\/j.ando.2025.101693_bib0450","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13023-024-03135-8","article-title":"Biallelic and monoallelic pathogenic variants in CYP24A1 and SLC34A1 genes cause idiopathic infantile hypercalcemia","volume":"19","author":"Wang","year":"2024","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.ando.2025.101693_bib0455","article-title":"Efficacy of oral cinacalcet in non-PTH nonmalignant hypercalcemia from excess 1,25-dihydroxyvitamin D","volume":"2","author":"Mohan","year":"2024","journal-title":"JCEM Case Rep"},{"key":"10.1016\/j.ando.2025.101693_bib0460","article-title":"Severe hypercalcemia due to primary hyperparathyroidism and heterozygous pathogenic variant of CYP24A1","volume":"1","author":"Liu","year":"2023","journal-title":"JCEM Case Rep"},{"key":"10.1016\/j.ando.2025.101693_bib0465","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/jbmr.4306","article-title":"Differential diagnosis of vitamin D-related hypercalcemia using serum vitamin D metabolite profiling","volume":"36","author":"Kaufmann","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"9","key":"10.1016\/j.ando.2025.101693_bib0470","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1210\/jc.2018-01074","article-title":"Hypercalcemia in glucagon cell hyperplasia and neoplasia (Mahvash syndrome): a new association","volume":"103","author":"Gild","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101693_bib0475","doi-asserted-by":"crossref","first-page":"e230032","DOI":"10.1530\/ERC-23-0032","article-title":"Glucagon cell hyperplasia and neoplasia: a recently recognized endocrine receptor disease","volume":"30","author":"Sipos","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2025.101693_bib0480","article-title":"Williams syndrome with severe hypercalcaemia","volume":"2018","author":"Gupta","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ando.2025.101693_bib0485","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1210\/jc.2016-2054","article-title":"Jansen metaphyseal chondrodysplasia due to heterozygous H223R-PTH1R mutations with or without overt hypercalcemia","volume":"101","author":"Nampoothiri","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101693_bib0490","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1210\/jc.2018-00332","article-title":"Progression of mineral ion abnormalities in patients with jansen metaphyseal chondrodysplasia","volume":"103","author":"Saito","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101693_bib0495","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/EJE-20-0625","article-title":"Inactivating PTH\/PTHrP signaling disorders (iPPSDs): evaluation of the new classification in a multicenter large series of 544 molecularly characterized patients","volume":"184","author":"Pereda","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2025.101693_bib0500","first-page":"1","article-title":"Immobilisation hypercalcaemia","volume":"83","author":"Mifsud","year":"2022","journal-title":"Br J Hosp Med (Lond)"},{"key":"10.1016\/j.ando.2025.101693_bib0505","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/nep.13246","article-title":"Immobilization-induced severe hypercalcaemia successfully treated with reduced dose of zoledronate in a maintenance haemodialysis patient","volume":"23","author":"Yamada","year":"2018","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ando.2025.101693_bib0510","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.eprac.2022.07.008","article-title":"Predictors of mortality in hypercalcemia of advanced chronic liver disease","volume":"28","author":"Majety","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ando.2025.101693_bib0515","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3892\/mco.2017.1127","article-title":"Persistent arthralgia, vomiting and hypercalcemia as the initial manifestations of hyperthyroidism: a case report","volume":"6","author":"Liu","year":"2017","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.ando.2025.101693_bib0520","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jss.2023.03.001","article-title":"Postoperative hypocalcemia in hyperthyroid patients: the parathyroids aren\u2019t always to blame","volume":"288","author":"Fields","year":"2023","journal-title":"J Surg Res"},{"key":"10.1016\/j.ando.2025.101693_bib0525","first-page":"e35206","article-title":"Rare presentation of a common disease: graves\u2019 thyrotoxicosis presented with non-parathyroid hypercalcemia and jaundice","volume":"15","author":"Ajwah","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ando.2025.101693_bib0530","first-page":"e28424","article-title":"An uncommon presentation of hyperthyroidism can culminate in devastating neurological consequences: a case report","volume":"14","author":"Abu-Abaa","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.ando.2025.101693_bib0535","doi-asserted-by":"crossref","first-page":"e251454","DOI":"10.1136\/bcr-2022-251454","article-title":"Hypercalcaemia as the initial presentation of Graves\u2019 disease","volume":"15","author":"Kaur","year":"2022","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ando.2025.101693_bib0540","doi-asserted-by":"crossref","first-page":"e6017","DOI":"10.1097\/MD.0000000000006017","article-title":"Hyperthyroidism-associated hypercalcemic crisis: a case report and review of the literature","volume":"96","author":"Chen","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ando.2025.101693_bib0545","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4103\/abr.abr_160_17","article-title":"A case of functional metastatic follicular thyroid carcinoma that presented with hip fracture and hypercalcemia","volume":"7","author":"Karimifar","year":"2018","journal-title":"Adv Biomed Res"},{"key":"10.1016\/j.ando.2025.101693_bib0550","doi-asserted-by":"crossref","first-page":"E2093","DOI":"10.1210\/jc.2012-2823","article-title":"Bone resorption is increased in pheochromocytoma patients and normalizes following adrenalectomy","volume":"97","author":"Veldhuis-Vlug","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101693_bib0555","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1210\/jc.2017-00169","article-title":"Lower bone mass and higher bone resorption in pheochromocytoma: importance of sympathetic activity on human bone","volume":"102","author":"Kim","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ando.2025.101693_bib0560","doi-asserted-by":"crossref","first-page":"e2271","DOI":"10.1210\/clinem\/dgaa142","article-title":"Clinical MEN-1 among a large cohort of patients with acromegaly","volume":"105","author":"Nachtigall","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101693_bib0565","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1007\/s11102-010-0286-8","article-title":"Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: case reports and review of the literature","volume":"Suppl.\u00a01","author":"Shah","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2025.101693_bib0570","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12902-021-00756-z","article-title":"Acromegaly and non-parathyroid hormone-dependent hypercalcemia: a case report and literature review","volume":"21","author":"Shi","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.ando.2025.101693_bib0575","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1210\/jc.2011-3188","article-title":"Pathophysiology of renal calcium handling in acromegaly: what lies behind hypercalciuria?","volume":"97","author":"Kamenick\u00fd","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101693_bib0580","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM197803162981101","article-title":"Treatment of hypoparathyroid patients with chlorthalidone","volume":"298","author":"Porter","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2025.101693_bib0585","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00774-005-0678-4","article-title":"Tamoxifen flare hypercalcemia: an additional support for gallium nitrate usage","volume":"24","author":"Arumugam","year":"2006","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.ando.2025.101693_bib0590","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4065\/84.3.261","article-title":"Milk-alkali syndrome","volume":"84","author":"Medarov","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ando.2025.101693_bib0595","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41574-018-0042-0","article-title":"Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement","volume":"14","author":"Mantovani","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2025.101693_bib0600","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000508985","article-title":"Recommendations for diagnosis and treatment of pseudohypoparathyroidism and related disorders: an updated practical tool for physicians and patients","volume":"93","author":"Mantovani","year":"2020","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.ando.2025.101693_bib0605","unstructured":"iPPSD, PTH\/PTHrP signaling inactivation pathologies (formerly pseudohypoparathyroidism and related diseases): https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2023-01\/pnds_ippsd_nov2022_texte.pdf."},{"key":"10.1016\/j.ando.2025.101693_bib0610","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","article-title":"The HYP Consortium A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets","volume":"11","year":"1995","journal-title":"Nat Genet"},{"issue":"10455","key":"10.1016\/j.ando.2025.101693_bib0615","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(24)01305-9","article-title":"X-linked hypophosphataemia","volume":"404","author":"Kamenick\u00fd","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2025.101693_bib0620","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41574-022-00662-x","article-title":"Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia","volume":"18","author":"Trombetti","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2025.101693_bib0625","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1681\/ASN.V9101845","article-title":"High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro","volume":"9","author":"Almaden","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ando.2025.101693_bib0630","doi-asserted-by":"crossref","first-page":"154049","DOI":"10.1016\/j.metabol.2019.154049","article-title":"Management of X-linked hypophosphatemia in adults","volume":"103S","author":"Lecoq","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.ando.2025.101693_bib0635","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00467-018-4180-3","article-title":"Risk of cardiovascular involvement in pediatric patients with X-linked hypophosphatemia","volume":"34","author":"Hern\u00e1ndez-Fr\u00edas","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ando.2025.101693_bib0640","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bone.2019.01.021","article-title":"Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia","volume":"121","author":"Zhang","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.ando.2025.101693_bib0645","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/jbmr.3992","article-title":"Hyperparathyroidism in patients with X-Linked hypophosphatemia","volume":"3","author":"Lecoq","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2025.101693_bib0650","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/joim.13593","article-title":"Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia","volume":"293","author":"Jan de Beur","year":"2023","journal-title":"J Intern Med"},{"key":"10.1016\/j.ando.2025.101693_bib0655","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1159\/000538037","article-title":"Medullary sponge kidney and its relationship with primary distal renal tubular acidosis: case reports and a comprehensive genetics first approach","volume":"148","author":"van den Berg","year":"2024","journal-title":"Nephron"},{"key":"10.1016\/j.ando.2025.101693_bib0660","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.kint.2024.01.031","article-title":"An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH)","volume":"105","author":"Zhu","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.ando.2025.101693_bib0665","doi-asserted-by":"crossref","first-page":"101843","DOI":"10.1016\/j.beem.2023.101843","article-title":"Inherited non-FGF23-mediated phosphaturic disorders: a kidney-centric review","volume":"38","author":"Walker","year":"2024","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101693_bib0670","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00774-023-01490-3","article-title":"Inherited Fanconi renotubular syndromes: unveiling the intricacies of hypophosphatemic rickets\/osteomalacia","volume":"42","author":"Ragate","year":"2024","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.ando.2025.101693_bib0675","doi-asserted-by":"crossref","first-page":"E1978","DOI":"10.1210\/jc.2012-1279","article-title":"Fanconi-Bickel syndrome and autosomal recessive proximal tubulopathy with hypercalciuria (ARPTH) are allelic variants caused by GLUT2 mutations","volume":"97","author":"Mannstadt","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101693_bib0680","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/ki.2013.380","article-title":"Microhematuria in a patient with beta-thalassemia major: a casual or a causal association?","volume":"86","author":"Piccoli","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.ando.2025.101693_bib0685","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ejendo\/lvae049","article-title":"Apparent mineralocorticoid excess in israel: a case series and literature review","volume":"190","author":"Lebel","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2025.101693_bib0690","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1007\/s12070-020-02304-y","article-title":"Osteitis fibrosis cystica: classical case report of an uncommon presentation in a young female","volume":"74","author":"Saini","year":"2022","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ando.2025.101693_bib0695","first-page":"e31757","article-title":"Multiple brown tumors secondary to parathyroid carcinoma: a challenging diagnosis","volume":"14","author":"Silva","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.ando.2025.101693_bib0700","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/RLU.0000000000004883","article-title":"False positive bone oligometastatic prostate cancer in 18 F-choline PET\/CT: be aware of chronic vascular pitfalls","volume":"48","author":"Pretet","year":"2023","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ando.2025.101693_bib0705","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/RLU.0000000000001113","article-title":"18F-choline PET\/CT-positive lytic bone lesions in prostate cancer and accidental myeloma detection","volume":"41","author":"Florimonte","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ando.2025.101693_bib0710","first-page":"e28329","article-title":"Hyperparathyroidism jaw-tumor syndrome: a case report from a radiological view","volume":"14","author":"Khan","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.ando.2025.101693_bib0715","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00256-013-1770-9","article-title":"Giant cell tumor of bone in a patient with diagnosis of primary hyperparathyroidism: a challenge in differential diagnosis with brown tumor","volume":"43","author":"Rossi","year":"2014","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.ando.2025.101693_bib0720","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00198-023-06878-5","article-title":"Multiple brown tumors: a bone complication due to long-term untreated pseudohypoparathyroidism","volume":"35","author":"Gonnelli","year":"2024","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ando.2025.101693_bib0725","doi-asserted-by":"crossref","first-page":"K11","DOI":"10.1093\/ejendo\/lvad025","article-title":"Immunohistochemical characterization of a steroid-secreting oncocytic adrenal carcinoma responsible for paraneoplastic hyperparathyroidism","volume":"188","author":"Haissaguerre","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2025.101693_bib0730","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00240-022-01355-w","article-title":"How useful is an oral calcium load test for diagnosing recurrent calcium stone formers?","volume":"50","author":"Tostivint","year":"2022","journal-title":"Urolithiasis"},{"key":"10.1016\/j.ando.2025.101693_bib0735","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.surg.2023.06.056","article-title":"Normocalcemic hyperparathyroidism: Intervention to differentiate primary from secondary hyperparathyroidism","volume":"175","author":"Baugh","year":"2024","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2025.101693_bib0740","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1210\/clinem\/dgae162","article-title":"Comparison of normocalcemic versus hypercalcemic primary hyperparathyroidism in a hypercalciuric renal stone population","volume":"109","author":"Halimi","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101693_bib0745","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/cen.12729","article-title":"A step towards cinacalcet testing for the diagnosis of primary hyperparathyroidism: comparison with the standardized intravenous calcium loading. A pilot study","volume":"8","author":"Cailleux","year":"2015","journal-title":"Clin Endocrinol (Oxford)"},{"key":"10.1016\/j.ando.2025.101693_bib0750","article-title":"Evaluation of the thiazide challenge test to differentiate primary from hypercalciuria-related hyperparathyroidism","author":"Verly","year":"2024","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426625000125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426625000125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T20:10:27Z","timestamp":1740514227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426625000125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0003426625000125"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2025.101693","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chapter 4: Differential diagnosis of primary hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2025.101693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101693"}}